Teva to Pay California $69 Million to Put Pay-for-Delay Claims to Rest

Drug Industry Daily
A A
Israeli drug titan Teva Pharmaceuticals and two other drugmakers have agreed to settlements in California in order to shake allegations of anticompetitive pay-for-delay deals.

To View This Article:

Login

Subscribe To Drug Industry Daily